# APYX (Apyx Medical Corp) - SEC EDGAR Financial Statements

> Apyx Medical Corp reported $59.57M in revenue and a net loss of $8.44M for the trailing twelve months ended September 30, 2026 (up 9.0% year over year), with a 63.4% gross margin and a -5.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/APYX
- Markdown: https://convexityos.com/fundamentals/APYX.md
- SEC CIK: 0000719135
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:48 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000719135&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $59.57M | +9.0% YoY |
| Operating Income | TTM | -$3.28M | -5.5% margin |
| Net Income | TTM | -$8.44M | -14.2% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$8.89M | -14.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $25.78M | Total debt: $39.75M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $52.84M | $48.10M | $52.35M | $44.51M | $48.52M | $27.71M | $28.23M | $16.61M | $10.23M | $8.82M |
| Cost of Revenue | $19.80M | $18.74M | $18.59M | $15.38M | $14.92M | $10.21M | $9.14M | $5.78M | $3.28M | $3.70M |
| **Gross Profit** | $33.04M | $29.36M | $33.76M | $29.13M | $33.60M | $17.50M | $19.09M | $10.83M | $6.96M | $5.12M |
| Research & Development | $3.37M | $5.08M | $5.44M | $4.54M | $4.32M | $3.92M | $3.73M | $2.55M | $1.94M | $1.03M |
| Selling, General & Admin | $15.80M | $18.86M | $22.20M | $20.48M | $18.62M | $11.69M | $13.70M | $9.41M | $8.69M | $6.18M |
| Total Operating Expenses | $39.49M | $48.20M | $53.70M | $52.69M | $48.05M | $37.59M | $39.96M | $25.10M | $20.84M | $16.51M |
| **Operating Income** | -$6.45M | -$18.84M | -$17.26M | -$23.56M | -$14.45M | -$20.08M | -$20.87M | -$14.28M | -$13.88M | -$11.39M |
| **EBITDA** | -$5.79M | -$18.25M | -$16.57M | -$22.67M | -$13.54M | -$19.20M | -$20.11M | -$13.61M | -$13.19M | -$10.66M |
| Interest Income | $1.11M | $1.61M | $921K | $157K | $11K | $241K | $1.39M | $616K | $0 | $0 |
| Interest Expense | $5.59M | $5.91M | $2.48M | $15K | $10K | $46K | $8.0K | $104K | $136K | $158K |
| Income Before Tax | -$10.84M | -$23.31M | -$21.28M | -$22.91M | -$14.82M | -$19.41M | -$19.84M | -$14.69M | -$13.84M | -$11.49M |
| Income Tax Expense | $270K | $252K | -$2.43M | $367K | $380K | -$7.50M | -$130K | -$3.91M | -$156K | $64K |
| **Net Income** | -$11.21M | -$23.46M | -$18.71M | -$23.18M | -$15.17M | -$11.90M | -$19.71M | $62.72M | -$5.06M | -$11.55M |
| Basic EPS | -$0.27 | -$0.66 | -$0.54 | -$0.67 | -$0.44 | -$0.35 | -$0.58 | $1.89 | -$0.16 | -$0.14 |
| **Diluted EPS** | -- | -- | -$0.54 | -$0.67 | -$0.44 | -$0.35 | -$0.58 | $1.83 | -$0.17 | -$0.15 |
| Basic Shares Outstanding | 41.1M | 35.5M | 34.6M | 34.5M | 34.3M | 34.2M | 34.1M | 33.2M | 31.4M | 27.4M |
| Diluted Shares Outstanding | -- | -- | 34.6M | 34.5M | 34.3M | 34.2M | 34.1M | 34.4M | 31.4M | 27.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $14.03M | $13.88M | $12.49M | $19.16M | $12.88M | $11.37M | $9.43M | $14.22M |
| Cost of Revenue | $5.03M | $5.01M | $4.57M | $7.17M | $4.58M | $4.29M | $3.77M | $5.26M |
| **Gross Profit** | $9.00M | $8.87M | $7.92M | $12.00M | $8.30M | $7.08M | $5.67M | $8.96M |
| Research & Development | $849K | $793K | $765K | $944K | $801K | $824K | $804K | $1.12M |
| Selling, General & Admin | $3.98M | $5.29M | $3.58M | $4.26M | $3.82M | $4.26M | $3.47M | $4.83M |
| Total Operating Expenses | $9.57M | $10.68M | $8.84M | $11.99M | $9.13M | $9.66M | $8.72M | $12.01M |
| **Operating Income** | -$571K | -$1.81M | -$911K | $11K | -$832K | -$2.57M | -$3.05M | -$3.05M |
| **EBITDA** | -$384K | -$1.61M | -$709K | $232K | -$668K | -$2.44M | -$2.91M | -$2.91M |
| Interest Income | $286K | $250K | $244K | $234K | $292K | $278K | $304K | $294K |
| Interest Expense | $1.41M | $1.39M | $1.37M | $1.41M | $1.41M | $1.39M | $1.38M | $1.65M |
| Income Before Tax | -$1.69M | -$2.95M | -$2.00M | -$1.15M | -$1.88M | -$3.69M | -$4.12M | -$4.57M |
| Income Tax Expense | $116K | $124K | $143K | $94K | $78K | $49K | $49K | $89K |
| **Net Income** | -$1.78M | -$3.24M | -$2.11M | -$1.30M | -$1.98M | -$3.78M | -$4.15M | -$4.63M |
| Basic EPS | -$0.04 | -$0.07 | -$0.05 | -- | -$0.05 | -$0.09 | -$0.10 | -- |
| Basic Shares Outstanding | 44.0M | 43.9M | 43.7M | -- | 40.7M | 40.7M | 40.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $31.74M | $31.74M | $43.65M | $10.19M | $30.87M | $41.91M | $58.81M | $32.41M | $16.60M | $40.66M |
| Short-Term Investments | -- | -- | -- | -- | -- | $39.66M | $0 | $40.88M | $61.68M | $55.48M |
| **Cash & Short-Term Investments** | $31.74M | $31.74M | $43.65M | $10.19M | $30.87M | $81.58M | $58.81M | $73.30M | $78.27M | $96.14M |
| Accounts Receivable, Net | $16.78M | $15.48M | $14.02M | $10.60M | $13.04M | $8.40M | $7.99M | $4.04M | $3.72M | $4.14M |
| Inventory | $8.60M | $7.56M | $9.92M | $11.80M | $6.78M | $4.05M | $5.07M | $3.01M | $3.15M | $6.04M |
| **Total Current Assets** | $58.47M | $56.44M | $70.36M | $42.97M | $60.74M | $66.09M | $76.73M | $85.32M | $89.83M | $106.9M |
| Property, Plant & Equipment, Net | $2.37M | $1.99M | $1.92M | $6.76M | $6.58M | $6.54M | $6.62M | $6.01M | $5.79M | $5.84M |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $185K | $185K | $185K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $190K | $191K | $32K |
| Other Non-Current Assets | $1.75M | $1.66M | $1.73M | $1.22M | $1.11M | $807K | $391K | $347K | $305K | $385K |
| **Total Non-Current Assets** | $8.37M | $8.40M | $8.88M | $8.80M | $7.98M | $8.02M | $8.01M | $6.54M | $6.09M | $6.23M |
| **Total Assets** | $66.84M | $64.84M | $79.24M | $51.77M | $68.72M | $74.11M | $84.75M | $91.86M | $95.93M | $113.2M |
| Accounts Payable | $3.06M | $2.62M | $2.71M | $2.67M | $2.63M | $1.51M | $2.44M | $1.50M | $1.42M | $2.35M |
| Short-Term Debt | -- | -- | -- | $0 | -- | -- | -- | -- | $0 | $0 |
| Deferred Revenue (Current) | -- | -- | $488K | $900K | $500K | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $11.70M | $10.72M | $12.74M | $11.85M | $13.21M | $9.15M | $12.31M | $8.62M | $8.61M | $22.44M |
| Long-Term Debt | $34.85M | $33.89M | $33.19M | $0 | -- | -- | -- | -- | $0 | $0 |
| Deferred Revenue (Non-Current) | $1.05M | $1.12M | $1.25M | $1.41M | $1.32M | $621K | $405K | $194K | $0 | -- |
| Other Non-Current Liabilities | $347K | $259K | $198K | $181K | $166K | $166K | $114K | $194K | $0 | -- |
| **Total Non-Current Liabilities** | $40.31M | $39.79M | $39.58M | $2.13M | $1.51M | $1.10M | $1.18M | $409K | $140K | $140K |
| **Total Liabilities** | $52.01M | $50.51M | $52.32M | $13.98M | $14.71M | $10.25M | $13.49M | $9.03M | $8.75M | $22.58M |
| **Total Debt (incl. Leases)** | $39.34M | $38.76M | $38.50M | $796K | $305K | $676K | $993K | $178K | $0 | $0 |
| Common Stock | $42K | $38K | $35K | $35K | $34K | $34K | $34K | $34K | $34K | $33K |
| Retained Earnings | -$89.12M | -$77.91M | -$54.45M | -$35.73M | -$12.55M | $2.62M | $14.52M | $28.61M | $34.22M | $38.77M |
| **Total Stockholders' Equity** | $14.54M | $14.21M | $26.70M | $37.58M | $53.70M | $63.72M | $71.26M | $82.83M | $87.18M | $90.60M |
| Total Equity | $14.83M | $14.34M | $26.92M | $37.79M | $54.01M | $63.86M | $71.26M | $82.83M | $87.18M | $90.60M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.78M | $27.62M | $31.14M | $31.74M | $25.14M | $29.30M | $31.01M | $31.74M |
| **Cash & Short-Term Investments** | $25.78M | $27.62M | $31.14M | $31.74M | $25.14M | $29.30M | $31.01M | $31.74M |
| Accounts Receivable, Net | $14.87M | $13.61M | $12.76M | $16.78M | $12.99M | $11.25M | $11.64M | $15.48M |
| Inventory | $11.95M | $10.75M | $9.54M | $8.60M | $9.14M | $8.19M | $7.68M | $7.56M |
| **Total Current Assets** | $53.84M | $53.16M | $54.80M | $58.47M | $48.79M | $49.91M | $51.85M | $56.44M |
| Property, Plant & Equipment, Net | $2.19M | $2.11M | $2.23M | $2.37M | $2.39M | $2.05M | $1.91M | $1.99M |
| Other Non-Current Assets | $1.74M | $1.78M | $1.88M | $1.75M | $1.81M | $1.72M | $1.77M | $1.66M |
| **Total Non-Current Assets** | $7.83M | $7.92M | $8.23M | $8.37M | $8.58M | $8.27M | $8.31M | $8.40M |
| **Total Assets** | $61.67M | $61.07M | $63.02M | $66.84M | $57.37M | $58.19M | $60.16M | $64.84M |
| Accounts Payable | $3.51M | $2.19M | $2.63M | $3.06M | $3.22M | $2.89M | $2.31M | $2.62M |
| **Total Current Liabilities** | $10.87M | $9.35M | $9.45M | $11.70M | $10.98M | $10.57M | $9.51M | $10.72M |
| Long-Term Debt | $35.57M | $35.33M | $35.09M | $34.85M | $34.61M | $34.37M | $34.13M | $33.89M |
| Deferred Revenue (Non-Current) | $1.17M | $1.13M | $1.13M | $1.05M | $1.22M | $1.19M | $1.19M | $1.12M |
| Other Non-Current Liabilities | $335K | $336K | $339K | $347K | $293K | $292K | $270K | $259K |
| **Total Non-Current Liabilities** | $40.76M | $40.63M | $40.49M | $40.31M | $40.31M | $40.17M | $40.01M | $39.79M |
| **Total Liabilities** | $51.63M | $49.98M | $49.94M | $52.01M | $51.28M | $50.73M | $49.52M | $50.51M |
| **Total Debt (incl. Leases)** | $39.75M | $39.63M | $39.46M | $39.34M | $39.21M | $39.08M | $38.92M | $38.76M |
| Common Stock | $42K | $42K | $42K | $42K | $38K | $38K | $38K | $38K |
| Retained Earnings | -$96.26M | -$94.47M | -$91.23M | -$89.12M | -$87.82M | -$85.84M | -$82.06M | -$77.91M |
| **Total Stockholders' Equity** | $9.63M | $10.66M | $12.83M | $14.54M | $5.85M | $7.25M | $10.51M | $14.21M |
| Total Equity | $10.04M | $11.09M | $13.09M | $14.83M | $6.08M | $7.46M | $10.64M | $14.34M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.11M | -$23.56M | -$18.85M | -$23.28M | -$15.20M | -$11.91M | -$19.71M | $62.72M | -$5.06M | -$11.55M |
| Depreciation & Amortization | $655K | $599K | $692K | $890K | $903K | $887K | $754K | $669K | $696K | $734K |
| Stock-Based Compensation | $2.00M | $4.01M | $5.11M | $6.70M | $5.09M | $4.21M | $3.58M | $2.22M | $871K | $809K |
| Change in Receivables | -$1.32M | -$2.04M | -$3.57M | $1.92M | -$4.90M | -$558K | -$3.97M | -$447K | -$303K | -$1.89M |
| Change in Inventory | -$1.07M | $2.26M | $1.46M | -$5.57M | -$2.86M | $615K | -$2.37M | $1.19M | -$368K | -$201K |
| Change in Payables | $355K | -$63K | $25K | $67K | $1.15M | -$965K | $1.05M | -$224K | -$23K | $392K |
| **Operating Cash Flow** | -$8.00M | -$18.05M | -$5.25M | -$20.28M | -$10.45M | -$16.07M | -$18.48M | -$20.88M | -$3.70M | -$2.84M |
| Capital Expenditure | -$1.11M | -$722K | -$533K | -$1.01M | -$723K | -$581K | -$1.30M | -$363K | -$624K | -$286K |
| **Free Cash Flow** | -$9.12M | -$18.77M | -$5.78M | -$21.29M | -$11.17M | -$16.65M | -$19.78M | -$21.24M | -$4.33M | -$3.12M |
| Purchases of Investments | -- | -- | -- | -- | -- | $0 | -$18.88M | -$87.19M | $0 | $0 |
| **Investing Cash Flow** | -$1.11M | -$722K | $6.73M | -$1.01M | -$723K | -$581K | $60.54M | $29.30M | -$624K | -$286K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $5.83M |
| **Financing Cash Flow** | $9.58M | $6.75M | $32.17M | $217K | $24K | -$73K | $147K | -$2.49M | -$239K | $5.71M |
| **Net Change in Cash** | -$1.0K | -$11.91M | $33.46M | -$20.68M | -$11.04M | -$16.90M | $42.22M | $5.93M | -$4.57M | $2.65M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.81M | -$3.07M | -$2.14M | -$1.24M | -$1.96M | -$3.74M | -$4.17M | -$4.66M |
| Depreciation & Amortization | $187K | $196K | $202K | $221K | $164K | $132K | $138K | $142K |
| Stock-Based Compensation | $753K | $1.07M | $312K | $500K | $530K | $520K | $451K | $838K |
| Change in Receivables | -$1.39M | -$946K | $3.95M | -$3.90M | -$1.84M | $471K | $3.94M | -$2.91M |
| Change in Inventory | -$1.33M | -$1.31M | -$845K | $511K | -$865K | -$521K | -$199K | $1.36M |
| Change in Payables | $1.34M | -$444K | -$411K | -$155K | $328K | $513K | -$331K | $756K |
| **Operating Cash Flow** | -$1.63M | -$3.49M | -$572K | -$2.53M | -$3.54M | -$1.23M | -$702K | -$2.94M |
| Capital Expenditure | -$265K | -$66K | -$60K | -$275K | -$519K | -$265K | -$55K | -$245K |
| **Free Cash Flow** | -$1.90M | -$3.56M | -$632K | -$2.81M | -$4.05M | -$1.50M | -$757K | -$3.18M |
| **Investing Cash Flow** | -$265K | -$66K | -$60K | -$275K | -$519K | -$265K | -$55K | -$245K |
| **Financing Cash Flow** | -$5.0K | -$5.0K | $83K | $9.48M | $45K | $25K | $25K | $6.76M |
| **Net Change in Cash** | -$1.84M | -$3.52M | -$603K | $6.61M | -$4.17M | -$1.71M | -$730K | $3.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 62.5% | 61.0% | 64.5% | 65.4% | 69.3% | 63.2% | 67.6% | 65.2% | 68.0% | 58.0% |
| **Operating Margin** | -12.2% | -39.2% | -33.0% | -52.9% | -29.8% | -72.5% | -73.9% | -86.0% | -135.7% | -129.2% |
| **Net Profit Margin** | -21.2% | -48.8% | -35.7% | -52.1% | -31.3% | -42.9% | -69.8% | 377.7% | -49.5% | -131.0% |
| Return on Equity (ROE) | -77.1% | -165.1% | -70.1% | -61.7% | -28.3% | -18.7% | -27.7% | 71.9% | -23.0% | -44.0% |
| Return on Assets (ROA) | -16.8% | -36.2% | -23.6% | -44.8% | -22.1% | -16.1% | -23.3% | 65.4% | -16.3% | -32.9% |
| Current Ratio | 5.00x | 5.26x | 5.52x | 3.63x | 4.60x | 7.22x | 6.23x | 10.43x | 3.77x | 5.03x |
| Quick Ratio | 4.26x | 4.56x | 4.74x | 2.63x | 4.09x | 6.78x | 5.82x | 10.07x | 3.06x | 3.87x |
| Debt to Equity | 2.71x | 2.73x | 1.44x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.12x | 0.11x |
| **Revenue Growth (YoY)** | +9.9% | -8.1% | +17.6% | -8.3% | +75.1% | -1.9% | +70.0% | +62.3% | +16.0% | -70.1% |
| Gross Profit Growth (YoY) | +12.5% | -13.0% | +15.9% | -13.3% | +92.0% | -8.3% | +76.4% | +55.6% | +36.0% | -59.3% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -131.4% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -130.7% | -- | -- | -141.2% |
| 5Y Revenue / Share Growth | +58.8% | +63.3% | +202.2% | +295.9% | +339.6% | -33.2% | -46.8% | -62.4% | -100.0% | -100.0% |
| 10Y Revenue / Share Growth | +6.0% | -13.2% | +13.5% | -99.9% | -99.9% | -41.9% | -48.0% | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -128.6% | -- | -- | -- | -- | -- | -100.5% | -106.8% |
| 10Y Net Income / Share Growth | -- | -- | -- | -101.9% | -107.1% | -- | -1740.0% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 63.4% | 63.5% | 63.2% | 62.5% | 62.6% | 61.6% | 61.5% | 61.0% |
| **Operating Margin** | -5.5% | -6.1% | -7.7% | -12.2% | -19.8% | -26.5% | -32.3% | -39.2% |
| **Net Profit Margin** | -14.2% | -14.8% | -16.4% | -21.2% | -30.4% | -37.1% | -42.4% | -48.8% |
| Return on Equity (ROE) | -87.6% | -81.0% | -71.5% | -77.1% | -248.6% | -238.0% | -190.6% | -165.1% |
| Return on Assets (ROA) | -13.7% | -14.1% | -14.5% | -16.8% | -25.3% | -29.7% | -33.3% | -36.2% |
| Current Ratio | 4.95x | 5.68x | 5.80x | 5.00x | 4.44x | 4.72x | 5.45x | 5.26x |
| Quick Ratio | 3.85x | 4.53x | 4.79x | 4.26x | 3.61x | 3.95x | 4.64x | 4.56x |
| Debt to Equity | 4.13x | 3.72x | 3.08x | 2.71x | 6.71x | 5.39x | 3.70x | 2.73x |
| **Revenue Growth (YoY)** | +9.0% | +22.1% | +32.4% | +34.7% | +12.1% | -6.4% | -7.9% | -3.0% |
| Gross Profit Growth (YoY) | +8.5% | +25.2% | +39.9% | +33.9% | +19.3% | -5.5% | -4.8% | +0.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
